Oppenheimer Asset Management Inc. Sells 13,880 Shares of Colgate-Palmolive (NYSE:CL)

Oppenheimer Asset Management Inc. decreased its position in Colgate-Palmolive (NYSE:CL - Free Report) by 49.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,980 shares of the company's stock after selling 13,880 shares during the quarter. Oppenheimer Asset Management Inc.'s holdings in Colgate-Palmolive were worth $1,451,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. GHE LLC boosted its position in Colgate-Palmolive by 1.6% during the 3rd quarter. GHE LLC now owns 20,938 shares of the company's stock valued at $2,138,000 after purchasing an additional 338 shares during the period. Pinnacle Financial Partners Inc boosted its position in Colgate-Palmolive by 1.1% during the 3rd quarter. Pinnacle Financial Partners Inc now owns 25,117 shares of the company's stock valued at $2,607,000 after purchasing an additional 279 shares during the period. MQS Management LLC acquired a new position in Colgate-Palmolive during the 3rd quarter valued at approximately $1,054,000. Empower Advisory Group LLC boosted its position in Colgate-Palmolive by 4.9% during the 3rd quarter. Empower Advisory Group LLC now owns 173,798 shares of the company's stock valued at $18,042,000 after purchasing an additional 8,047 shares during the period. Finally, Carrera Capital Advisors boosted its position in Colgate-Palmolive by 23.1% during the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company's stock valued at $4,066,000 after purchasing an additional 7,353 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on CL. StockNews.com upgraded Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Thursday. Jefferies Financial Group lowered Colgate-Palmolive from a "buy" rating to a "hold" rating and reduced their price target for the stock from $103.00 to $95.00 in a research report on Wednesday, July 24th. HSBC reissued a "hold" rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and boosted their price objective for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. Finally, Barclays boosted their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an "equal weight" rating in a research note on Monday, July 29th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $105.11.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the business's stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The trade was a 16.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company's stock.

Colgate-Palmolive Stock Up 1.5 %

NYSE:CL traded up $1.36 during trading hours on Monday, hitting $94.92. 2,397,363 shares of the company's stock traded hands, compared to its average volume of 4,378,353. The firm has a market cap of $77.55 billion, a P/E ratio of 26.81, a P/E/G ratio of 3.34 and a beta of 0.42. Colgate-Palmolive has a twelve month low of $75.17 and a twelve month high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The stock's fifty day moving average price is $99.31 and its two-hundred day moving average price is $98.54.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.11%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive's payout ratio is 57.31%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.